SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 40.98 |
Enterprise Value ($M) | 37.87 |
Book Value ($M) | 84.10 |
Book Value / Share | 13.81 |
Price / Book | 0.49 |
NCAV ($M) | -14.75 |
NCAV / Share | -2.42 |
Price / NCAV | -2.78 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.02 |
Return on Assets (ROA) | -0.02 |
Return on Equity (ROE) | -0.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.44 |
Current Ratio | 3.98 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 54.36 |
Assets | 153.21 |
Liabilities | 69.11 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Renaissance Technologies Llc | 5.55 | -9.75 | |
13G/A | Dimensional Fund Advisors Lp | 7.20 | -14.12 | |
13G/A | Caldwell Securities, Inc | 7.40 | -3.43 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
38 | 1,050 | 3.62 | |
466 | 983 | 47.41 | |
5,326 | 21,826 | 24.40 | |
1 | 4,682 | 0.02 | |
909 | 7,800 | 11.65 | |
(click for more detail) |
Similar Companies | |
---|---|
MRNS – Marinus Pharmaceuticals, Inc. | MRUS – Merus N.V. |
MURA – Mural Oncology plc | NAMS – NewAmsterdam Pharma Company N.V. |
NGNE – Neurogene Inc. |
Financial data and stock pages provided by
Fintel.io